BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 474189)

  • 1. 1 alpha-hydroxyvitamin D3 treatment of therapy-resistant symptomatic hypocalcemia in a hypoparathyroid patient with intestinal malabsorption.
    Hylander E; Madsen S
    Acta Med Scand; 1979; 205(7):603-5. PubMed ID: 474189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1 alpha-hydroxyvitamin D3 in intestinal calcium malabsorption. A pilot study.
    Hylander E; Jarnum S
    Scand J Gastroenterol; 1980; 15(4):443-8. PubMed ID: 7433906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypocalcaemia induced by glucocorticoids in a child with hypoparathyroidism treated with 1-alpha-hydroxyvitamin D3.
    Vardi P; Benderly A; Etzioni A; Levy J; Hochberg Z
    Eur J Pediatr; 1985 Sep; 144(3):280-2. PubMed ID: 4054169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of postsurgical hypoparathyroidism by intramuscular injection of vitamin D3 in a patient associated with malabsorption syndrome due to multiple abdominal surgeries.
    Seki T; Yamamoto M; Ohwada R; Takano K; Kure M; Sekine H; Katsura Y; Sato K
    J Bone Miner Metab; 2010 Mar; 28(2):227-32. PubMed ID: 19657589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
    N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Subcutaneous Recombinant Parathyroid Hormone (1-34) Infusion in the Management of Childhood Hypoparathyroidism Associated with Malabsorption.
    Saraff V; Rothenbuhler A; Högler W; Linglart A
    Horm Res Paediatr; 2018; 89(4):271-277. PubMed ID: 28926829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: hypoparathyroidism and iron storage disease. Treatment with 25-hydroxy-vitamin D3.
    Mautalen CA; Kvicala R; Perriard D; Bugnard E; Rossi E; Duhart J
    Am J Med Sci; 1978; 276(3):363-8. PubMed ID: 742642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium imbalance in hypoparathyroidism.
    Gupta MM
    J Assoc Physicians India; 1991 Aug; 39(8):616-8. PubMed ID: 1669288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
    Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
    Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malabsorption with idiopathic hypoparathyroidism responding to treatment for coincident celiac sprue.
    Matsueda K; Rosenberg IH
    Dig Dis Sci; 1982 Mar; 27(3):269-73. PubMed ID: 7075423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Derivatives of vitamin d: basic considerations and therapeutic applications (author's transl)].
    Flury W; Descoeudres C
    Ther Umsch; 1979 Oct; 36(10):908-14. PubMed ID: 394383
    [No Abstract]   [Full Text] [Related]  

  • 12. 1alpha-hydroxycholecalciferol in the treatment of hypoparathyroidism.
    Jorgensen H; Vogt JH
    Acta Med Scand; 1977 Jan; 201(1-2):3-7. PubMed ID: 835368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoparathyroidism--a long-term follow-up experience with 1 alpha-vitamin D3 therapy.
    Halabe A; Arie R; Mimran D; Samuel R; Liberman UA
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):303-7. PubMed ID: 8187292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism.
    Neer RM; Holick MF; DeLuca HF; Potts JT
    Metabolism; 1975 Dec; 24(12):1403-13. PubMed ID: 1196134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between the 5,6-cis and 5,6-trans isomers of 25-hydroxyvitamin D3 in chronic hypoparathyroidism.
    Offermann G; Kraft D
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):784-93. PubMed ID: 579038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-dihydroxycholecalciferol in hypoparathyroidism.
    Davies M; Taylor CM; Hill LF; Stanbury SW
    Lancet; 1977 Jan; 1(8002):55-9. PubMed ID: 63708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocalcaemia following thyroidectomy unresponsive to oral therapy.
    Etheridge ZC; Schofield C; Prinsloo PJ; Sturrock ND
    Hormones (Athens); 2014; 13(2):286-9. PubMed ID: 24776629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-Alpha-hydroxycholecalciferol in the treatment of hypocalcaemic psychosis.
    Gertner JM; Hodsman AB; Neuberger JN
    Clin Endocrinol (Oxf); 1976 Sep; 5(5):539-43. PubMed ID: 186220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-dihydroxy-vitamin D3: a new treatment for hypoparathyroidism.
    Glatthaar C; Smith R; Espiner EA; Donald RA; Hinton D
    N Z Med J; 1980 Oct; 92(669):267-71. PubMed ID: 6934421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of conventional doses of 1 alpha, 25-dihydroxycholecalciferol to correct hypocalcemia in a girl with idiopathic hypoparathyroidism.
    Chesney RW; Horowitz SD; Kream BE; Eisman JA; Hong R; DeLuca HF
    N Engl J Med; 1977 Dec; 297(23):1272-5. PubMed ID: 917074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.